23. Symposium of the AGNP

Abstracts (HTML) List of Authors

Jachau, K.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Jacob, A.

Analysis of cerebrospinal fluid of depressed patients

Jacob, W.

Validation of a genetic mouse model for anxiety and comorbid depression

Jacobi, F.

High cholesterol, triglycerides, and body-mass index in suicide attempters with major depression

Jäger, L.

Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI

Jäger, M.

Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up

Jahn, H.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment
Gender effects in pharmacological relapse prevention of alcoholism
Megestrol attenuates hormonal response to CCK-4
Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptide
Gender effects in depression: Influence of HPA axis activity and steroid synthesis inhibitors

Jahn, T.

D2 dopamine receptor occupancy during treatment with flupentixol decanoate in comparison to risperidone, olanzapine, clozapine, haloperidol and haloperidol decanoate – A 123I-IBZM SPECT study: D2 receptor occupancy under flupentixol decanoate

Jakob, F.

Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM

Janssen, B.

How do psychiatrists and schizophrenic patients assess treatment and outcome in outpatient care?
Subjective quality of life and treatment strategies in schizophrenia outpatient care
Cost effectiveness of different treatment strategies in schizophrenia outpatient care

Jaquenoud-Sirot, E.

Interactions between somatic and psychotropic drugs: pharmacokinetic and pharmacodynamic consequences.

Jockers-Scherübl, M. C.

Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: A double-blind placebo-controlled study
Cannabis and multiple substance abuse raise the serum concentrations of the neurotrophins NGF and BDNF in drug-naïve schizophrenic patients

Johann, M.

High-frequency transcranial magnetic stimulation decreases cigarette smoking

Jordan, W.

Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition
Quetiapine improves sleep quality in healthy subjects
Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy
Circulating big endothelin-1 is disproportionately elevated in obstructive sleep apnea

Juckel, G.

EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline
Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease
Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants
Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression
Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI
Prediction of treatment response in major depression: The relationship between the serotonin-related LDAEP and the unspecific prediction related to anterior cingulate cortex activity
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*
Kinematic analysis of the effect of neuroleptics on facial expressions and hand writing in schizophrenic patients